BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lupu CM, Eisenbach C, Kuefner MA, Schmidt J, Lupu AD, Stremmel W, Encke J. An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. J Gastrointest Surg 2006;10:635-45. [PMID: 16713537 DOI: 10.1007/BF03239969] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Hofmeyer KA, Ray A, Zang X. The contrasting role of B7-H3. Proc Natl Acad Sci USA. 2008;105:10277-10278. [PMID: 18650376 DOI: 10.1073/pnas.0805458105] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 6.5] [Reference Citation Analysis]
2 Barach YS, Lee JS, Zang X. T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Trends Mol Med 2011;17:47-55. [PMID: 20971039 DOI: 10.1016/j.molmed.2010.09.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
3 Yuan C, Zhao X, Wangmo D, Alshareef D, Gates TJ, Subramanian S. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer. Pharmacol Ther 2021;:107981. [PMID: 34480964 DOI: 10.1016/j.pharmthera.2021.107981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thompson RH, Kwon ED, Allison JP. Inhibitors of B7-CD28 costimulation in urologic malignancies. Immunotherapy 2009;1:129-39. [PMID: 20445772 DOI: 10.2217/1750743X.1.1.129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Barone R, Caruso Bavisotto C, Rappa F, Gargano ML, Macaluso F, Paladino L, Vitale AM, Alfano S, Campanella C, Gorska M, Di Felice V, Cappello F, Venturella G, Marino Gammazza A. JNK pathway and heat shock response mediate the survival of C26 colon carcinoma bearing mice fed with the mushroom Pleurotus eryngii var. eryngii without affecting tumor growth or cachexia. Food Funct 2021;12:3083-95. [PMID: 33720221 DOI: 10.1039/d0fo03171b] [Reference Citation Analysis]
6 Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø. B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. BMC Cancer 2014;14:602. [PMID: 25139714 DOI: 10.1186/1471-2407-14-602] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
7 Azuma T, Sato Y, Ohno T, Azuma M, Kume H. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer. PLoS One 2020;15:e0243379. [PMID: 33306717 DOI: 10.1371/journal.pone.0243379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Aulino P, Berardi E, Cardillo VM, Rizzuto E, Perniconi B, Ramina C, Padula F, Spugnini EP, Baldi A, Faiola F. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363. [PMID: 20615237 DOI: 10.1186/1471-2407-10-363] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 7.9] [Reference Citation Analysis]
9 Luo L, Zhu G, Xu H, Yao S, Zhou G, Zhu Y, Tamada K, Huang L, Flies AD, Broadwater M, Ruff W, van Deursen JM, Melero I, Zhu Z, Chen L. B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets. PLoS One 2015;10:e0130126. [PMID: 26065426 DOI: 10.1371/journal.pone.0130126] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
10 Zhou WT, Jin WL. B7-H3/CD276: An Emerging Cancer Immunotherapy. Front Immunol 2021;12:701006. [PMID: 34349762 DOI: 10.3389/fimmu.2021.701006] [Reference Citation Analysis]
11 Li K, Wei X, Zhang G, Li M, Zhang X, Zhou C, Hou J, Yuan H. Different expression of B7-H3 in the caput, corpus, and cauda of the epididymis in mouse. BMC Urol 2017;17:23. [PMID: 28376772 DOI: 10.1186/s12894-017-0215-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Wang C, Feng H, Cheng X, Liu K, Cai D, Zhao R. Potential Therapeutic Targets of B7 Family in Colorectal Cancer. Front Immunol 2020;11:681. [PMID: 32477326 DOI: 10.3389/fimmu.2020.00681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Janakiram M, Shah UA, Liu W, Zhao A, Schoenberg MP, Zang X. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3. Immunol Rev 2017;276:26-39. [PMID: 28258693 DOI: 10.1111/imr.12521] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 17.2] [Reference Citation Analysis]
14 Narayanan NK, Kunimasa K, Yamori Y, Mori M, Mori H, Nakamura K, Miller G, Manne U, Tiwari AK, Narayanan B. Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo. Cancer Med 2015;4:1767-80. [PMID: 26408414 DOI: 10.1002/cam4.520] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
15 Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y. Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 2009;101:1709-16. [PMID: 19844235 DOI: 10.1038/sj.bjc.6605375] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 7.7] [Reference Citation Analysis]
16 Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG, Zhao H. B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med. 2013;31:283-291. [PMID: 23242015 DOI: 10.3892/ijmm.2012.1212] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
17 Yang S, Wei W, Zhao Q. B7-H3, a checkpoint molecule, as a target for cancer immunotherapy. Int J Biol Sci 2020;16:1767-73. [PMID: 32398947 DOI: 10.7150/ijbs.41105] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 17.0] [Reference Citation Analysis]
18 Malara N, Trunzo V, Foresta U, Amodio N, De Vitis S, Roveda L, Fava M, Coluccio M, Macrì R, Di Vito A, Costa N, Mignogna C, Britti D, Palma E, Mollace V. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med 2016;14:133. [PMID: 27176720 DOI: 10.1186/s12967-016-0876-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
19 Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev. 2009;229:145-151. [PMID: 19426220 DOI: 10.1111/j.1600-065x.2009.00768.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 67] [Article Influence: 8.8] [Reference Citation Analysis]
20 Steinert G, Schölch S, Koch M, Weitz J. Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg. 2012;397:535-542. [PMID: 22350614 DOI: 10.1007/s00423-012-0917-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
21 Sun J, Fu F, Gu W, Yan R, Zhang G, Shen Z, Zhou Y, Wang H, Shen B, Zhang X. Origination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune system. PLoS One 2011;6:e24751. [PMID: 21931843 DOI: 10.1371/journal.pone.0024751] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
22 Wu D, Zhang Z, Pan H, Fan Y, Qu P, Zhou J. Upregulation of the B7/CD28 family member B7-H3 in bladder cancer. Oncol Lett 2015;9:1420-4. [PMID: 25663925 DOI: 10.3892/ol.2014.2828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
23 Pant A, Medikonda R, Lim M. Alternative Checkpoints as Targets for Immunotherapy. Curr Oncol Rep 2020;22:126. [PMID: 33141349 DOI: 10.1007/s11912-020-00983-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kobori H, Hashiguchi M, Piao J, Kato M, Ritprajak P, Azuma M. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Immunology 2010;130:363-73. [PMID: 20141543 DOI: 10.1111/j.1365-2567.2009.03236.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
25 Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci U S A 2008;105:10495-500. [PMID: 18650384 DOI: 10.1073/pnas.0802423105] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 8.6] [Reference Citation Analysis]
26 Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, Allison JP. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA. 2007;104:19458-19463. [PMID: 18042703 DOI: 10.1073/pnas.0709802104] [Cited by in Crossref: 250] [Cited by in F6Publishing: 236] [Article Influence: 16.7] [Reference Citation Analysis]